吴清：适度拓宽券商资本空间与杠杆上限；中国央行连续第13个月增持黄金丨盘前情报

Market Performance - A-shares saw collective gains across the three major indices from December 1 to December 5, with the Shanghai Composite Index closing at 3902.81 points, up 0.70% for the week; the Shenzhen Component Index at 13147.68 points, up 1.08%; and the ChiNext Index at 3109.30 points, up 1.36% [2] - A total of 1818 stocks rose during the week, while 464 stocks declined; 87 stocks increased by over 15%, and 17 stocks decreased by over 15% [2] - The aerospace equipment, industrial metals, and engineering machinery sectors led the gains, with respective increases of 10.42%, 9.14%, and 5.86% on December 5 [2] International Market Overview - The New York stock market indices rose on December 5, with the Dow Jones Industrial Average up 104.05 points to 47954.99, a gain of 0.22%; the S&P 500 up 13.28 points to 6870.40, a gain of 0.19%; and the Nasdaq Composite up 72.99 points to 23578.13, a gain of 0.31% [4] - European indices showed mixed results, with the UK FTSE 100 down 43.86 points to 9667.01, a decline of 0.45%, while the German DAX index rose 146.11 points to 24028.14, an increase of 0.61% [4] Oil Prices - International oil prices saw slight increases on December 5, with light crude oil futures for January 2026 rising by $0.41 to $60.08 per barrel, a gain of 0.69%; and Brent crude oil futures for February rising by $0.49 to $63.75 per barrel, a gain of 0.77% [4] Industry Insights - The China Securities Regulatory Commission emphasized the need for industry institutions to shift from price competition to value competition, enhancing resource integration capabilities among leading firms and focusing on niche markets for smaller firms [6] - The regulatory framework will be strengthened to optimize evaluation metrics for quality institutions and explore differentiated regulatory policies for smaller and foreign institutions [6] Healthcare Sector Developments - The National Healthcare Security Administration and the Ministry of Human Resources and Social Security released new drug directories, effective January 1, 2026, which include 114 new drugs, 50 of which are classified as innovative [10] - The new directories aim to standardize drug listings and ensure continuity of care for patients during the transition period [8] Investment Trends - Analysts predict a structural bull market in 2026, driven by rising technology and cyclical profits, with a focus on technology growth and cyclical growth as key investment themes [18] - The market is currently in a waiting phase for policy developments, with expectations of a rebound if new policies exceed market expectations [18]